The homegrown PE fund ChrysCapital has invested about Rs 600 crore ($70 million) in Ahmedabad-based La Renon Healthcare, valuing it at $800 million. ChrysCap has acquired about 8% stake from the promoter family in a...
Warburg buys majority stake in ophthalmic device company Appasamy
US private equity firm Warburg Pincus has bought a majority stake in Chennai-based Appasamy Associates, India’s largest maker of ophthalmic equipment and intraocular lenses (IOLs). Financial details of the...
Warburg Pincus acquires Chennai’s Appasamy Associates
Warburg Pincus, a leading global investor, has acquired a stake in leading manufacturer of ophthalmic equipment and devices Appasamy Associates, stated a company release. Based in Chennai, Appasamy is the largest Indian...
Denmark’s Genmab to acquire ProfoundBio for $1.8 billion
Danish biotech Genmab has agreed to buy privately owned U.S. cancer drug maker ProfoundBio for $1.8 billion, the two companies said on Wednesday. The acquisition will give Genmab worldwide rights to three candidates in...
Beige to offload 2.9% stake in Mankind Pharma through block deals
Beige Ltd., an affiliate of ChrysCapital, is looking to sell a portion of its stake in Mankind Pharma Ltd. through block deals. As per a term sheet reviewed by Mint, Beige Ltd. is offering to sell up to 11.63 million...
Novo Nordisk to buy Cardior Pharma for up to $1 billion
Novo Nordisk A/S agreed to buy Cardior Pharmaceuticals for up to $1 billion ($1.1 billion) as the Danish maker of weight-loss drugs continues to expand into treatments for cardiovascular disease. The maker of hit...
AbbVie to bolster immunity illness drug pipeline with Landos deal
AbbVie will buy drug developer Landos Biopharma for up to $212 million as the Humira-maker aims to expand its pipeline of medicines to treat immune system-related illnesses, the companies said on Monday. Landos is...
AstraZeneca to buy fusion for $2 billion
AstraZeneca said on Tuesday it will buy Canadian drug developer Fusion Pharmaceuticals for $2 billion in cash as the drugmaker bets on next-generation cancer treatments. The deal gives AstraZeneca a foothold in the...
Eris Lifesciences acquires Biocon Biologics domestic branded formulation business for Rs 1,242 crore
Eris Lifesciences on Thursday announced the acquisition of Biocon Biologics’ India branded formulation business for Rs. 1,242 crore. Eris has also signed a 10-year supply agreement with Biocon Biologics as a part of...
Suven Pharma, Cohance Lifesciences to merge to bolster CDMO business
Suven Pharmaceuticals Ltd and Cohance Lifesciences Ltd signed a definitive agreement to merge their businesses, which will further strengthen the former’s position in the contract development and manufacturing...
KKR considers selling stake in India’s $3 billion JB Pharma
KKR & Co. is exploring options including selling its controlling stake in India’s JB Chemicals & Pharmaceuticals Ltd. amid interest from potential buyers, according to people familiar with the matter. The US...
Nirma issues bonds to fund Glenmark Life Sciences acquisition: Bankers
India’s Nirma has accepted bids aggregating to 35 billion rupees ($422 million) for a three-part shorter-tenor bonds to fund its acquisition of a 75% stake in Glenmark Pharma’s life sciences unit, three...
